GT Biopharma (GTBP) EPS (Basic) (2010 - 2026)
GT Biopharma (GTBP) posted quarterly EPS (Basic) of -$0.11 for Q1 2026, up 66.38% year-over-year from -$0.07 in Q1 2025, and up 91.84% quarter-over-quarter from -$1.36 in Q4 2025.
GT Biopharma (GTBP) EPS (Basic) (2010 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported EPS (Basic) for 17 consecutive years, with -$0.11 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 66.38% year-over-year to -$0.11; the TTM figure through Mar 2026 stood at -$1.22 (up 75.42% YoY), while the FY2025 annual figure was -$6.25, up 9.93% from the prior year.
- EPS (Basic) climbed to -$0.11 in Q1 2026 per GTBP's latest filing, from -$1.36 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.04 in Q3 2025 and bottomed at -$211.32 in Q2 2022.
- Historically, EPS (Basic) has averaged -$23.35 across 5 years, with a median of -$2.19 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 5288.38% — and 2025, when it soared 168.1%.
- GT Biopharma's EPS (Basic) stood at -$107.99 in 2022, then soared by 97.97% to -$2.19 in 2023, then increased by 9.04% to -$1.99 in 2024, then jumped by 31.48% to -$1.36 in 2025, then jumped by 91.84% to -$0.11 in 2026.
- Business Quant data shows GTBP's EPS (Basic) at -$0.11 in Q1 2026, -$1.36 in Q4 2025, and $1.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | GT Biopharma | 8.38 Mn | 8.38 Mn | - | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.11 |
| Dec 31, 2025 | -1.36 |
| Sep 30, 2025 | 1.04 |
| Jun 30, 2025 | -10.92 |
| Mar 31, 2025 | -0.33 |
| Dec 31, 2024 | -1.99 |
| Sep 30, 2024 | -1.53 |
| Jun 30, 2024 | -2.17 |
| Mar 31, 2024 | -2.14 |
| Dec 31, 2023 | -2.19 |
| Sep 30, 2023 | -2.19 |
| Jun 30, 2023 | -2.86 |
| Mar 31, 2023 | -2.85 |
| Dec 31, 2022 | -107.99 |
| Sep 30, 2022 | -24.88 |
| Jun 30, 2022 | -211.32 |
| Mar 31, 2022 | -23.25 |
| Dec 31, 2021 | -19.39 |
| Sep 30, 2021 | -5.66 |
| Jun 30, 2021 | -3.92 |